This arthritis drug may improve Covid survival in elderlies – Daijiworld.com

London, Nov 16 (IANS): Scientists have claimed that a type of arthritis drug called ‘baricitinib’ may reduce the risk of dying among elderly patients infected with Covid-19.
This medication is usually used to treat rheumatoid arthritis, and was initially identified by the Imperial College London using artificial intelligence as a drug that could have anti-viral and anti-inflammatory effects.
In the early-stage study, 83 patients, with a median age of 81 and all suffering from moderate to severe…

Click here to view the original article.